ANI Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ANIP and other ETFs, options, and stocks.

About ANIP

ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. 

CEO
Nikhil Lalwani
CEONikhil Lalwani
Employees
970
Employees970
Headquarters
Baudette, Minnesota
HeadquartersBaudette, Minnesota
Founded
1996
Founded1996
Employees
970
Employees970

ANIP Key Statistics

Market cap
1.77B
Market cap1.77B
Price-Earnings ratio
20.78
Price-Earnings ratio20.78
Dividend yield
Dividend yield
Average volume
288.24K
Average volume288.24K
High today
High today
Low today
Low today
Open price
$79.11
Open price$79.11
Volume
0.00
Volume0.00
52 Week high
$99.50
52 Week high$99.50
52 Week low
$62.61
52 Week low$62.61

Stock Snapshot

As of today, ANI Pharmaceuticals(ANIP) shares are valued at $77.72. The company's market cap stands at 1.77B, with a P/E ratio of 20.78.

On 2026-07-21, ANI Pharmaceuticals(ANIP) stock opened at $79.11, reached a high of —, and a low of —.

ANI Pharmaceuticals(ANIP) shares are trading with a volume of 0, against a daily average of 288.24K.

In the last year, ANI Pharmaceuticals(ANIP) shares hit a 52-week high of $99.50 and a 52-week low of $62.61.

In the last year, ANI Pharmaceuticals(ANIP) shares hit a 52-week high of $99.50 and a 52-week low of $62.61.

ANIP News

Simply Wall St 9h
ANI Pharmaceuticals On Strong ILUVIEN Trial Data Is The Stock A Bargain

ANI Pharmaceuticals (ANIP) recently reported statistically significant Phase 4 SYNCHRONICITY trial results for its fluocinolone acetonide intravitreal implant,...

ANI Pharmaceuticals On Strong ILUVIEN Trial Data Is The Stock A Bargain
Simply Wall St 3d
ANI Pharmaceuticals Stock Looks Fairly Valued With Strong Returns But Mixed Earnings

ANI Pharmaceuticals has delivered a strong 139.1% return over the past 5 years, yet at around US$79.20 the valuation checks now suggest the stock is closer to f...

ANI Pharmaceuticals Stock Looks Fairly Valued With Strong Returns But Mixed Earnings
TipRanks 5d
ANI Pharmaceuticals intends to appeal rulings in CG Oncology matter

ANI Pharmaceuticals (ANIP) announced that Judge Sheldon K. Rennie, on July 16, denied ANI’s post-trial motions for a new trial and judgment as a matter of law....

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

People also own

Based on the portfolios of people who own ANIP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.